For several months now, the current U.S. administration has consistently attacked and endeavored to weaken biomedical research and public health action in the United States and worldwide with unparalleled vigor. This situation has many consequences – both ethical and economic – but above all it is a grave attack on healthcare protection, and an unprecedented assault on the systems and institutions responsible for protecting lives.

CLEVELAND, Ohio (Jan 28, 2026)—Although perimenopause is experienced by all women regardless of race or nationality, it is not always experienced similarly. Studies comparing perimenopause symptoms across diverse cultures and geographic settings are lacking. A new study based on data from Flo, an international mobile health application, demonstrated inconsistency between perimenopause knowledge and actual symptoms experienced across diverse global populations. Study results are published online today in Menopause, the journal of The Menopause Society.

Highlights

•Epithelial-to-mesenchymal transition (EMT) induces phenotypic changes necessary for tumor cell survival and progression.

•Other cell populations, such as fibroblasts, immune and hypoxic cells, introduce EMT-promoting factors.

•Stress-related stimuli such as hypoxia, chemotherapy, and nutrient deprivation promote EMT in tumors.

The word ‘dissociation’ has grown in popularity and become embedded in everyday language, but while the term has gained traction in popular culture and mental health advocacy, misconceptions persist – including some which are harmful, experts say.

A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective treatment option for the NHS in treating moderate and severe forms of depression that have not responded to other treatments.

The economic analysis, which is published in BMJ Mental Health, compared TMS to usual care in specialist mental health services, and found that TMS reduces depressive symptoms, eases pressures on informal carers and on NHS resources, and helps people get back to work.

TMS represents an investment in care that recovers its costs over time, primarily from savings to the wider health service and from fewer workdays being lost because of long-term depression.